Maxmedo

Delhi, India Founded: 2023 • Age: 3 yrs
Provides pharmaceutical distribution, tender support, and stock management for institutions.

About Maxmedo

Maxmedo is a Healthcare company based in Delhi (India) founded in 2023. It provides pharmaceutical distribution, tender support, and stock management for institutions. It operates on a B2B model. Its Indian entity Maxmedo Private Limited reported revenue of β‚Ή65.9 Lakh. Maxmedo offers products and services including Tender Support Service, Stock Liquidation Service, and Product Promotion Service. Its focus areas include Hospital Supplies, Pharma Products, Pharmaceuticals and Distribution. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Maxmedo Private Ltd focuses on distributing pharmaceuticals and offering government business services like tender assistance and stock liquidation. They support hospitals, nursing homes, and state institutions by partnering with companies such as Cipla and Lupin. Based in New Delhi, India, they ensure efficient supply chain management and quality assurance for healthcare providers.

  • Headquarters Delhi, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website maxmedo.in
  • Legal Name Maxmedo Private Ltd
  • Date of Incorporation 16 Jun, 2023
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹65.9 Lakh

    FY 2025 · +219% YoY

  • Net Profit
    ₹15,539

    FY 2025 · 0% margin

  • EBITDA
    ₹2.1 Lakh

    FY 2025 · 3% margin

Products & Services of Maxmedo

Maxmedo offers a comprehensive portfolio of products and services, including Tender Support Service, Stock Liquidation Service, and Product Promotion Service.

Tender Support Service
Government Business

Assists in pharmaceutical tender processes and documentation

Stock Liquidation Service
Inventory Management

Manages pharmaceutical stock to reduce waste efficiently

Product Promotion Service
Marketing Support

Promotes pharmaceutical products in national health programs

Board of directors of Maxmedo Private Limited (Maxmedo)

Maxmedo Private Limited is the primary company behind Maxmedo. The board of Maxmedo Private Limited currently have 2 directors; the longest-serving is Manish Sachan, appointed in 2023.

DirectorDesignationAppointedTenureEntity
Manish Sachan
DIN 10203404
Director16 Jun 20233 yrs 4 moMaxmedo Private Limited
Maneesha Sachan
DIN 08791816
Director16 Jun 20233 yrs 4 moMaxmedo Private Limited

Financials of Maxmedo

Figures of Maxmedo Private Limited, the primary company behind Maxmedo, for FY 2025. Revenue was ₹65.9 Lakh (+219% year on year). Net profit was ₹15,539 (0% margin). EBITDA was ₹2.1 Lakh (3% margin).

  • ₹65.9 LakhRevenue · FY 2025 · +219% YoY
  • ₹15,539Net profit · 0% margin
  • ₹2.1 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Maxmedo Private Limited are on its company page.

Premium access

Detailed financial statements for Maxmedo

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Maxmedo

Maxmedo has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Maxmedo

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Maxmedo

Maxmedo was founded in 2023.

Maxmedo is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind Maxmedo, Maxmedo Private Limited, reported revenue of β‚Ή65.9 Lakh for FY 2025, up 219% year on year.

Maxmedo Private Ltd focuses on distributing pharmaceuticals and offering government business services like tender assistance and stock liquidation. They support hospitals, nursing homes, and state institutions by partnering with companies such as Cipla and Lupin. Based in New Delhi, India, they ensure efficient supply chain management and quality assurance for healthcare providers.

Maxmedo's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Maxmedo offers Tender Support Service, Stock Liquidation Service, and Product Promotion Service.

Maxmedo operates through Maxmedo Private Limited.

The legal entities of Maxmedo currently have 2 directors, including Manish Sachan, Maneesha Sachan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available